Assenagon Asset Management S.A. Intra Cellular Therapies, Inc. Transaction History

Assenagon Asset Management S.A.

$47.8 Billion
Q3 2024

A detailed history of Assenagon Asset Management S.A. transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 232,933 shares of ITCI stock, worth $17.9 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

232,933

Previous 342,843 32.06%

Holding current value

$17.9 Million

Previous $23.5 Million 27.46%

% of portfolio

0.04%

Previous 0.06%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$67.99 - $80.84 $7.47 Million - $8.89 Million	-109,910 Reduced 32.06%	232,933 $17 Million
Q2 2024 Jul 18, 2024	SELL	$64.76 - $79.84 $19.9 Million - $24.5 Million	-306,974 Reduced 47.24%	342,843 $23.5 Million
Q1 2024 Apr 24, 2024	SELL	$64.37 - $75.65 $7.35 Million - $8.64 Million	-114,157 Reduced 14.94%	649,817 $45 Million
Q4 2023 Jan 17, 2024	BUY	$46.37 - $73.65 $12.8 Million - $20.3 Million	275,368 Added 56.36%	763,974 $54.7 Million
Q3 2023 Nov 06, 2023	BUY	$52.09 - $64.1 $15.5 Million - $19.1 Million	298,303 Added 156.75%	488,606 $25.5 Million
Q2 2023 Jul 25, 2023	BUY	$54.67 - $66.44 $3.14 Million - $3.82 Million	57,492 Added 43.29%	190,303 $12 Million
Q1 2023 Apr 18, 2023	BUY	$43.8 - $56.99 $2.3 Million - $3 Million	52,583 Added 65.54%	132,811 $7.19 Million
Q4 2022 Jan 12, 2023	BUY	$44.07 - $54.45 $1.45 Million - $1.79 Million	32,806 Added 69.18%	80,228 $4.25 Million
Q3 2022 Oct 27, 2022	BUY	$42.7 - $59.99 $351,506 - $493,837	8,232 Added 21.01%	47,422 $2.21 Million
Q2 2022 Jul 27, 2022	SELL	$43.0 - $65.64 $2.3 Million - $3.51 Million	-53,510 Reduced 57.72%	39,190 $2.24 Million
Q1 2022 Apr 25, 2022	SELL	$38.74 - $62.09 $1.37 Million - $2.2 Million	-35,411 Reduced 27.64%	92,700 $5.67 Million
Q4 2021 Feb 01, 2022	BUY	$35.2 - $53.42 $4.51 Million - $6.84 Million	128,111 New	128,111 $6.71 Million
Q2 2021 Jul 15, 2021	SELL	$29.3 - $44.5 $6.1 Million - $9.27 Million	-208,301 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$30.8 - $39.51 $132,840 - $170,406	4,313 Added 2.11%	208,301 $7.07 Million
Q4 2020 Feb 01, 2021	SELL	$23.34 - $32.22 $6.35 Million - $8.76 Million	-271,906 Reduced 57.14%	203,988 $6.49 Million
Q3 2020 Oct 07, 2020	BUY	$17.61 - $31.86 $3.68 Million - $6.66 Million	209,143 Added 78.4%	475,894 $12.2 Million
Q2 2020 Jul 21, 2020	BUY	$14.35 - $26.64 $1.73 Million - $3.21 Million	120,612 Added 82.53%	266,751 $6.85 Million
Q1 2020 Apr 17, 2020	BUY	$12.31 - $33.12 $1.57 Million - $4.21 Million	127,194 Added 671.39%	146,139 $2.25 Million
Q4 2019 Jan 17, 2020	BUY	$7.26 - $38.49 $137,540 - $729,193	18,945 New	18,945 $650,000

Others Institutions Holding ITCI

# of Institutions

398

Shares Held

87.5M

Call Options Held

309K

Put Options Held

302K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.25B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Intra Cellular Therapies, Inc. Transaction History